Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of paclitaxel in treating patients who have refractory or recurrent endometrial cancer.

Timeline

Start

2001-06

Primary completion

2002-10

Completion

—

Drugs

Indications